Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Study of Avatrombopag in Chronic ITP
NCT00625443Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in immune thrombocytopenia (ITP), sponsored by Eisai Co., Ltd.. Started May 2007; status: completed.
02
Drugs
avatrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00625443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625443.